Fig. 16 (abstract P211).From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part twoUSP6 Potentiates IFN Signaling In Vitro. RD_ES/USP6(Pooled) or RD-ES lines were treated with 1000 U/mL IFNa of IFNB for the indicated time period. USP6 extended the duration and amplified the magnitude of STAT1 and STAT3 activationBack to article page